Semaglutide, a medication primarily used for the treatment of type 2 diabetes and obesity, has garnered significant attention in the UK for its efficacy in weight loss and glycemic control. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which mimics the action of a naturally occurring hormone that regulates appetite and blood sugar levels. By enhancing insulin secretion and reducing...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian